Effect of vitiligo on self-reported health-related quality of life
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Vitiligo is a pigmentary disorder affecting at least 1% of the total population. Although the disease does not produce direct physical impairment, it may considerably influence the psychological well-being of the patients. It has been suggested that patients suffer from low self-esteem, poor body image and a poor quality of life. The majority of the studies on the psychosocial impact of vitiligo were conducted in the U.S.A. and England. OBJECTIVES: This study aims to quantify the burden of vitiligo by estimating health-related quality of life in the Dutch-speaking Belgian population (Flanders). This is compared with the level of disability caused by psoriasis in a similarly recruited population. It is also our purpose to detect those at risk of experiencing a poor quality of life and to identify variables that might predict this impairment. PATIENTS AND METHODS: Patients with vitiligo (n = 119) and 162 patients with psoriasis were included in a postal survey. In order to obtain a patient-based measurement of quality of life we used the Dermatology Life Quality Index (DLQI), a widely validated questionnaire that is easy to use and allows comparison between several skin disorders. Other survey questions were related to demographic data and disease-related characteristics. RESULTS: We obtained excellent response rates in both patient groups. The overall mean DLQI score for vitiligo (4.95) was lower than that for psoriasis (6.26) (P = 0.01). Patients with vitiligo experienced significantly less impairment of life quality from the symptoms and treatment of the disease (P < 0.001). The highest individual mean scores in vitiligo were found for Q2 (feelings), Q4 (clothing), Q5 (social and leisure activities) and Q3 (daily routine). The interaction of disease and sex on the DLQI score was highly significant (P = 0.001). While men with vitiligo scored significantly lower than men with psoriasis (P < 0.001), we found a comparable overall DLQI score for women in these disease groups. The number of consultations (P = 0.005) and severity of the disease (P < 0.001) were independently related to the DLQI. CONCLUSIONS: Our study quantifies the burden on the quality of life caused by vitiligo and indicates specific areas of patients' lives which are most affected by the disease. Sex, number of consultations and subjective disease severity independently predict the quality of life. The quality of life impairment in women affected with vitiligo equals the impairment caused by psoriasis in our study population. These results should awake the interest of physicians in this 'cosmetic' disease, since appropriate treatment is likely to improve the quality of life of vitiligo patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Psoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Who should measure quality of life, the doctor or the patient?
Slevin, M., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.20 · Cited by 904
The effect of severe psoriasis on the quality of life of 369 patients
Finlay, A. Y., & Coles, E. C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb05019.x · Cited by 550
Skin disease and handicap: An analysis of the impact of skin conditions
Jowett, S., & Ryan, T. (1985) · Social Science & Medicine · doi:10.1016/0277-9536(85)90021-8 · Cited by 383
Quality of life measurement in dermatology: a practical guide
FINLAY, A. Y. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.5541510.x · Cited by 333
Quantifying the harmful effect of psoriasis on health-related quality of life
Weiss, S. C., Kimball, A. B., Liewehr, D. J., Blauvelt, A., Turner, M. L., & Emanuel, E. J. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122755 · Cited by 265
Psychiatric morbidity in vitiligo: prevalence and correlates in India
Mattoo, S., Handa, S., Kaur, I., Gupta, N., & Malhotra, R. (2002) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2002.00590.x · Cited by 222
Psychologic effects of vitiligo: A critical incident analysis
Kent, G., & Al'Abadie, M. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90112-7 · Cited by 214
Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers
KENT, G., & AL-ABADIE, M. (1996) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.1996.d01-219.x · Cited by 189
Quality of life assessments in dermatology
Finlay, A. Y. (1998) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(98)80026-6 · Cited by 175
Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome
Parsad, D., Pandhi, R., Dogra, S., Kanwar, A. J., & Kumar, B. K. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05097_9.x · Cited by 171
Badia, Mascaró, Lozano, & ON BEHALF OF THE CAVIDE RESEARCH GROUP (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03112.x · Cited by 170
Porter, J. R., Beuf, A. H., Lerner, A., & Nordlund, J. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70160-6 · Cited by 170
The effect of vitiligo on sexual relationships
Porter, J. R., Beuf, A. H., Lerner, A. B., & Nordlund, J. J. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70028-g · Cited by 167
Cosmetic camouflage advice improves quality of life
Holme, S. A., Beattie, P. E., & Fleming, C. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04900.x · Cited by 150
Psychological reaction to chronic skin disorders
Porter, J. R., Beuf, A. H., Nordlund, J. J., & Lerner, A. B. (1979) · General Hospital Psychiatry · doi:10.1016/0163-8343(79)90081-1 · Cited by 146
Impaired quality of life of adults with skin disease in primary care
Harlow, D., Poyner, T., Finlay, A. Y., & Dykes, P. J. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03830.x · Cited by 145
Quality of life in dermatology
Halioua, B., Beumont, M. G., & Lunel, F. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00793.x · Cited by 131
Response to cosmetic disfigurement: patients with vitiligo.
Porter, J. R., Ah, B., Lerner, A. B., & Nordlund, J. J. (1987) · PubMed · Cited by 122
Wahl, A. K., Loge, J. H., Wiklund, I. E., & Hanestad, B. R. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107501 · Cited by 114
Psychiatric Morbidity in Vitiligo and Psoriasis: A Comparative Study from India
Mattoo, S. K., Handa, S., Kaur, I., Gupta, N., & Malhotra, R. (2001) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2001.tb00004.x · Cited by 108
Nichol, M. B., Margolies, J. E., Lippa, E. A., et al. (1996) · PharmacoEconomics · doi:10.2165/00019053-199610060-00010 · Cited by 97
Postal questionnaire study of disability in the community associated with psoriasis
O'Neill, P., & Kelly, P. J. (1996) · BMJ · doi:10.1136/bmj.313.7062.919 · Cited by 90
DISABILITY AND HANDICAP IN DERMATOLOGY
Finlay, A. Y., & Ryan, T. J. (1996) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1996.tb03628.x · Cited by 76
Jobanputra, R., & Bachmann, M. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00073.x · Cited by 71
Handicap in Darier's disease and Hailey-Hailey disease
Harris, A., BURGE, S. M., Dykes, P. J., & Finlay, A. Y. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1102.x · Cited by 68
Personal Responses of Patients to Vitiligo: The Importance of the Patient-Physician Interaction
Porter, J. (1978) · Archives of Dermatology · doi:10.1001/archderm.1978.01640210075025 · Cited by 64
Cited by
Basra, M. K. A., Fenech, R., Gatt, R. M., Salek, M. S., & Finlay, A. Y. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08832.x · Cited by 789
Vitiligo: A comprehensive overview
Alikhan, A., Felsten, L. M., Daly, M., & Petronic-Rosic, V. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.061 · Cited by 708
The burden of skin disease in the United States
Lim, H. W., Collins, S. A. B., Resneck, J. S., Bolognia, J. L., Hodge, J. A., Rohrer, T. A., Van Beek, M. J., Margolis, D. J., Sober, A. J., Weinstock, M. A., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.043 · Cited by 520
New discoveries in the pathogenesis and classification of vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.048 · Cited by 476
Guideline for the diagnosis and management of vitiligo
Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J., Anstey, A. V., Ingham, J., & Young, K. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08881.x · Cited by 332
Metadata
- Authors
- Ongenae, K., Van Geel, N., De Schepper, S., & Naeyaert, J. M.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06
- Volume
- 152
- Issue
- 6
- Pages
- 1165-1172
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W1970907037
- Cited by
- 254
- References
- 28
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.